LIFECORE BIOMEDICAL, INC. DE (LFCR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-25. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 200M 400M 600M FY16: 476.9M FY17: 469.8M FY18: 524.2M FY19: 557.6M FY20: 160.1M FY21: 100.9M FY22: 111.3M FY23: 103.3M FY24: 128.3M FY25: 128.9M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 30M 60M 90M FY16: 66.8M FY17: 79.2M FY18: 78.3M FY19: 81M FY20: 39.4M FY21: 38.9M FY22: 39.1M FY23: 28M FY24: 41.9M FY25: 40.3M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-27M -18M -9M 0 9M 18M 27M FY16: -20.6M FY17: 14.7M FY18: 13.6M FY19: 5.5M FY20: -25.9M FY21: -8.8M FY22: -11.8M FY23: -21.8M FY24: -8.8M FY25: -17.2M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-120M -80M -40M 0 40M 80M 120M FY16: -11.6M FY17: 10.6M FY18: 24.8M FY19: 411K FY20: -38.2M FY21: -32.3M FY22: -116.7M FY23: -99.6M FY24: 12M FY25: -38.7M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 200M 400M 600M FY16: 410.1M FY17: 390.6M FY18: 445.9M FY19: 476.6M FY20: 120.7M FY21: 61.9M FY22: 72.2M FY23: 75.3M FY24: 86.4M FY25: 88.6M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-30M -15M 0 15M 30M 45M FY16: 20.8M FY17: 29.8M FY18: 19.8M FY19: 16M FY20: -17M FY21: 16.5M FY22: -22.6M FY23: -17.4M FY24: 257K FY25: -206K FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M FY15: 9.1M FY16: -18.9M FY17: 6.8M FY18: -13.8M FY19: -28.7M FY20: -29.3M FY21: -2.8M FY22: -48.8M FY24: -18.1M FY25: -13.6M FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 15M 30M 45M FY16: 27M FY17: 27.7M FY18: 27.9M FY19: 28.6M FY20: 29.2M FY21: 29.3M FY22: 29.5M FY23: 30M FY24: 36.7M FY25: 34.8M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q1 '16: 0.52 Q2 '16: 0.47 Q3 '16: -0.45 Q4 '16: -0.43 Q1 '17: -0.42 Q2 '17: -0.44 Q3 '17: 0.47 Q4 '17: 0.39 Q1 '18: 0.35 Q2 '18: 0.32 Q3 '18: 0.76 Q4 '18: 0.89 Q1 '19: 0.82 Q2 '19: 0.78 Q3 '19: 0.25 Q4 '19: 0.01 Q1 '20: -0.16 Q2 '20: -0.37 Q3 '20: -0.80 Q4 '20: -1.30 Q1 '21: -1.52 Q2 '21: -1.74 Q3 '21: -1.54 Q4 '21: -1.06 Q1 '22: -1.00 Q2 '22: -1.85 Q3 '22: -2.11 Q4 '22: -3.95 Q1 '23: -4.00 Q2 '23: -3.13 Q3 '23: -3.88 Q4 '23: -3.32 Q1 '24: -3.30 Q2 '24: -2.48 Q3 '24: -0.86 Q4 '24: 0.33 Q1 '25: 0.15 Q2 '25: -0.49 Q3 '25: -1.33 Q4 '25: -1.26 Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.